Effects of catalytic hydrogenation on coal liquids which exhibit microbial mutagenic activity

Abstract

An interdisciplinary strategy is outlined for characterizing the disposition of bioactive (toxic, teratogenic, mutagenic, and/or carcinogenic) materials in coal‐derived hydrocarbon liquids during upgrading processing. Engineering input is required to select representative PDU and pilot‐scale samples and appropriate processing schemes and conditions for upgrading experiments to ensure reliable extrapolation of results to demonstration and commercial scale. Biology expertise is required to perform and interpret short‐term in vitro cellular assays and whole‐animal toxicity and carcinogenesis testing on raw and upgraded samples. Chemical separation and identification of active classes and components in the samples aid in interpreting bioactivity results and in quantifying effects of various upgrading processes and conditions. The end result will be a data base for reliably assessing and addressing potential occupational and environmental safety and health concerns associated with upgraded coal‐derived liquids.

An example of the value of this interdisciplinary approach is given by work performed on generically representative raw and hydrotreated SRC‐II gas oil samples. Biological and chemical characterization indicates significant loss of bioactivity during hydrotreatment, with one postulated mechanism being removal of primary amine groups from multi‐ring aromatic compounds.